Lataa...
Thiazolidinediones and Cardiovascular Risk — A Question of Balance
BACKGROUND: Several recent meta-analyses of adverse event data from randomized controlled trials with rosiglitazone reveal a possible association between this thiazolidinedione and an increased risk of ischemic myocardial events. This has led to debate on the overall clinical benefit of glitazone th...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Bentham Science Publishers Ltd.
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2822138/ https://ncbi.nlm.nih.gov/pubmed/20676274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/157340309788970333 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|